We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Strikes Deal on Pay-for-Delay Suit with Endo, Refiles Case Against Allergan
FTC Strikes Deal on Pay-for-Delay Suit with Endo, Refiles Case Against Allergan
The Federal Trade Commission reached an agreement with Endo to settle claims that the company blocked the market entry of Opana ER and Lidoderm generics, and then refiled a lawsuit against Allergan and its former subsidiary Watson Laboratories with identical charges.